A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

NCT05540873 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CellabMED